Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sandro Cosconati

Showing results (1-10 of 150) with videos related to

Pageof 15
Sort By:
Journal of Chemical Information and Modeling|July 16, 2021
PyRMD: A New Fully Automated AI-Powered Ligand-Based Virtual Screening ToolGiorgio Amendola, Sandro Cosconati
Journal of Medicinal Chemistry|June 11, 2014
The first sphingosine 1-phosphate lyase inhibitors against multiple sclerosis: a successful drug discovery taleSandro Cosconati, Ettore Novellino
Journal of Medicinal Chemistry|April 2, 2005
Architecture of the human urotensin II receptor: comparison of the binding domains of peptide and non-peptide urotensin II agonistsAntonio Lavecchia, Sandro Cosconati, Ettore Novellino
Nature Structural & Molecular Biology|December 6, 2016
A balance between elongation and trimming regulates telomere stability in stem cellsTeresa Rivera, Candy Haggblom, Sandro Cosconati, et al.
Journal of Medicinal Chemistry|March 6, 2007
Characterizing the 1,4-dihydropyridines binding interactions in the L-type Ca2+ channel: model construction and docking calculationsSandro Cosconati, Luciana Marinelli, Antonio Lavecchia, et al.
Chemmedchem|August 8, 2006
Modeling of Cdc25B dual specifity protein phosphatase inhibitors: docking of ligands and enzymatic inhibition mechanismAntonio Lavecchia, Sandro Cosconati, Vittorio Limongelli, et al.
Molecular Informatics|August 23, 2016
Best Matching Protein Conformations and Docking Programs for a Virtual Screening Campaign Against SMO ReceptorGiorgio Amendola, Danilo Di Maio, Valeria La Pietra, et al.
Current Topics in Medicinal Chemistry|December 30, 2011
From the pharmacophore to the homology model of the benzodiazepine receptor: the indolyglyoxylamides affairBarbara Cosimelli, Sandro Cosconati, Luciana Marinelli, et al.
Journal of Chemical Information and Modeling|June 11, 2026
AI-Enforced Ultra-Large Virtual Screening Discovers Potent CD28 BindersSaurabh Upadhyay, Michele Roggia, Shaoren Yuan, et al.
Journal of Chemical Information and Modeling|May 19, 2026
PyRMD Studio: A Unified Suite for Next-Generation, AI-Powered Virtual ScreeningBenito Natale, Muhammad Waqas, Michele Roggia, et al.
Pageof 15

Showing results (1-10 of 150) with videos related to

Sort By:
Pageof 15
Journal of Chemical Information and Modeling|July 16, 2021
PyRMD: A New Fully Automated AI-Powered Ligand-Based Virtual Screening ToolGiorgio Amendola, Sandro Cosconati
Journal of Medicinal Chemistry|June 11, 2014
The first sphingosine 1-phosphate lyase inhibitors against multiple sclerosis: a successful drug discovery taleSandro Cosconati, Ettore Novellino
Journal of Medicinal Chemistry|April 2, 2005
Architecture of the human urotensin II receptor: comparison of the binding domains of peptide and non-peptide urotensin II agonistsAntonio Lavecchia, Sandro Cosconati, Ettore Novellino
Nature Structural & Molecular Biology|December 6, 2016
A balance between elongation and trimming regulates telomere stability in stem cellsTeresa Rivera, Candy Haggblom, Sandro Cosconati, et al.
Journal of Medicinal Chemistry|March 6, 2007
Characterizing the 1,4-dihydropyridines binding interactions in the L-type Ca2+ channel: model construction and docking calculationsSandro Cosconati, Luciana Marinelli, Antonio Lavecchia, et al.
Chemmedchem|August 8, 2006
Modeling of Cdc25B dual specifity protein phosphatase inhibitors: docking of ligands and enzymatic inhibition mechanismAntonio Lavecchia, Sandro Cosconati, Vittorio Limongelli, et al.
Molecular Informatics|August 23, 2016
Best Matching Protein Conformations and Docking Programs for a Virtual Screening Campaign Against SMO ReceptorGiorgio Amendola, Danilo Di Maio, Valeria La Pietra, et al.
Current Topics in Medicinal Chemistry|December 30, 2011
From the pharmacophore to the homology model of the benzodiazepine receptor: the indolyglyoxylamides affairBarbara Cosimelli, Sandro Cosconati, Luciana Marinelli, et al.
Journal of Chemical Information and Modeling|June 11, 2026
AI-Enforced Ultra-Large Virtual Screening Discovers Potent CD28 BindersSaurabh Upadhyay, Michele Roggia, Shaoren Yuan, et al.
Journal of Chemical Information and Modeling|May 19, 2026
PyRMD Studio: A Unified Suite for Next-Generation, AI-Powered Virtual ScreeningBenito Natale, Muhammad Waqas, Michele Roggia, et al.
Pageof 15